Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cholesterol is fat in the blood. It is produced by the liver and is found in foods of animal origin, such as meat, poultry, and full-fat dairy products. The body needs some cholesterol to ensure organ growth and normal functioning. However, if there is too much cholesterol in the blood, it may stick to the walls of the arteries and narrow or even block, and there is a risk of coronary artery disease and other heart diseases. Lifestyle changes and unhealthy eating habits cannot be completely resolved. In this case, the doctor may recommend the use of a cholesterol-lowering drug. The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments.
The growth of the global cholesterol medicine market is driven by a variety of factors. For example, due to modern society, people’s poor lifestyles and lack of exercise lead to increased cholesterol in the body, and the prevalence of cardiovascular disease and obesity rises. The constant attention to health care and the increasing awareness of drugs have promoted the expansion of the cholesterol-lowering drug market; the government has increased its investment in cholesterol drug research to improve the quality of clinical diagnosis; the development of medical technology has also promoted the development of cholesterol drugs. However, the high cost of research and the lack of skilled labor will hinder the growth of the global cholesterol drug market.
The report details the trend, potential and market size of Cholesterol Lowering Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cholesterol Lowering Drugmarket, defines the market attractiveness level of Cholesterol Lowering Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cholesterol Lowering Drug industry, describes the types of Cholesterol Lowering Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cholesterol Lowering Drug market and the development prospects and opportunities of Cholesterol Lowering Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cholesterol Lowering Drug market in Chapter 13.
By Player:
Quest Diagnostics Incorporated
Pfizer Inc
Sanofi SA
Kowa Company
Randox Laboratories
Clinical Reference Laboratory Inc
LabCorp
AbbVie Inc
Novartis AG
Daiichi Sankyo Company Limited
AstraZeneca
Amgen Inc
Merck & Co
Bristol-Myers Squibb (BMS)
Cell Biolabs Inc
By Type:
Statins
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
PCSK9 Inhibitors
Other
By End-User:
Hypercholesterolemia
Cardiovascular Diseases
Hyperlipidemia
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cholesterol Lowering Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cholesterol Lowering Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cholesterol Lowering Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cholesterol Lowering Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cholesterol Lowering Drug Market Analysis and Outlook to 2022
-
7.1 Global Cholesterol Lowering Drug Consumption (2017-2022)
-
7.2 United States Cholesterol Lowering Drug Consumption (2017-2022)
-
7.3 Europe Cholesterol Lowering Drug Consumption (2017-2022)
-
7.4 China Cholesterol Lowering Drug Consumption (2017-2022)
-
7.5 Japan Cholesterol Lowering Drug Consumption (2017-2022)
-
7.6 India Cholesterol Lowering Drug Consumption (2017-2022)
-
7.7 South Korea Cholesterol Lowering Drug Consumption (2017-2022)
8 Region and Country-wise Cholesterol Lowering Drug Market Analysis and Outlook to 2028
-
8.1 Global Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.2 United States Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.3 Europe Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.4 China Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.5 Japan Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.6 India Cholesterol Lowering Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Cholesterol Lowering Drug Consumption Forecast (2022-2028)
9 Global Cholesterol Lowering Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Cholesterol Lowering Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Statins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bile Acid Sequestrants Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cholesterol Absorption Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Fibric Acid Derivatives Consumption and Growth Rate (2017-2022)
-
9.1.5 Global PCSK9 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Cholesterol Lowering Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hyperlipidemia Consumption and Growth Rate (2017-2022)
10 Global Cholesterol Lowering Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Cholesterol Lowering Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bile Acid Sequestrants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cholesterol Absorption Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Fibric Acid Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global PCSK9 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cholesterol Lowering Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)
11 Global Cholesterol Lowering Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cholesterol Lowering Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cholesterol Lowering Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cholesterol Lowering Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cholesterol Lowering Drug Market Competitive Analysis
-
14.1 Quest Diagnostics Incorporated
-
14.1.1 Quest Diagnostics Incorporated Company Details
-
14.1.2 Quest Diagnostics Incorporated Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Quest Diagnostics Incorporated Cholesterol Lowering Drug Product and Service
-
14.2 Pfizer Inc
-
14.2.1 Pfizer Inc Company Details
-
14.2.2 Pfizer Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Inc Cholesterol Lowering Drug Product and Service
-
14.3 Sanofi SA
-
14.3.1 Sanofi SA Company Details
-
14.3.2 Sanofi SA Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi SA Cholesterol Lowering Drug Product and Service
-
14.4 Kowa Company
-
14.4.1 Kowa Company Company Details
-
14.4.2 Kowa Company Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kowa Company Cholesterol Lowering Drug Product and Service
-
14.5 Randox Laboratories
-
14.5.1 Randox Laboratories Company Details
-
14.5.2 Randox Laboratories Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Randox Laboratories Cholesterol Lowering Drug Product and Service
-
14.6 Clinical Reference Laboratory Inc
-
14.6.1 Clinical Reference Laboratory Inc Company Details
-
14.6.2 Clinical Reference Laboratory Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Clinical Reference Laboratory Inc Cholesterol Lowering Drug Product and Service
-
14.7 LabCorp
-
14.7.1 LabCorp Company Details
-
14.7.2 LabCorp Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 LabCorp Cholesterol Lowering Drug Product and Service
-
14.8 AbbVie Inc
-
14.8.1 AbbVie Inc Company Details
-
14.8.2 AbbVie Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AbbVie Inc Cholesterol Lowering Drug Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Cholesterol Lowering Drug Product and Service
-
14.10 Daiichi Sankyo Company Limited
-
14.10.1 Daiichi Sankyo Company Limited Company Details
-
14.10.2 Daiichi Sankyo Company Limited Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Daiichi Sankyo Company Limited Cholesterol Lowering Drug Product and Service
-
14.11 AstraZeneca
-
14.11.1 AstraZeneca Company Details
-
14.11.2 AstraZeneca Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AstraZeneca Cholesterol Lowering Drug Product and Service
-
14.12 Amgen Inc
-
14.12.1 Amgen Inc Company Details
-
14.12.2 Amgen Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Amgen Inc Cholesterol Lowering Drug Product and Service
-
14.13 Merck & Co
-
14.13.1 Merck & Co Company Details
-
14.13.2 Merck & Co Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Merck & Co Cholesterol Lowering Drug Product and Service
-
14.14 Bristol-Myers Squibb (BMS)
-
14.14.1 Bristol-Myers Squibb (BMS) Company Details
-
14.14.2 Bristol-Myers Squibb (BMS) Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bristol-Myers Squibb (BMS) Cholesterol Lowering Drug Product and Service
-
14.15 Cell Biolabs Inc
-
14.15.1 Cell Biolabs Inc Company Details
-
14.15.2 Cell Biolabs Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Cell Biolabs Inc Cholesterol Lowering Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cholesterol Lowering Drug
-
Figure Cholesterol Lowering Drug Picture
-
Table Global Cholesterol Lowering Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cholesterol Lowering Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cholesterol Lowering Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cholesterol Lowering Drug Consumption by Country (2017-2022)
-
Figure United States Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Figure China Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Figure India Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cholesterol Lowering Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Cholesterol Lowering Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cholesterol Lowering Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Statins Consumption and Growth Rate (2017-2022)
-
Figure Global Bile Acid Sequestrants Consumption and Growth Rate (2017-2022)
-
Figure Global Cholesterol Absorption Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Fibric Acid Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global PCSK9 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Hyperlipidemia Consumption and Growth Rate (2017-2022)
-
Figure Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bile Acid Sequestrants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cholesterol Absorption Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fibric Acid Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PCSK9 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cholesterol Lowering Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cholesterol Lowering Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Quest Diagnostics Incorporated (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Incorporated Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Incorporated Cholesterol Lowering Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Cholesterol Lowering Drug Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Cholesterol Lowering Drug Product and Service
-
Table Kowa Company (Foundation Year, Company Profile and etc.)
-
Table Kowa Company Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kowa Company Cholesterol Lowering Drug Product and Service
-
Table Randox Laboratories (Foundation Year, Company Profile and etc.)
-
Table Randox Laboratories Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Randox Laboratories Cholesterol Lowering Drug Product and Service
-
Table Clinical Reference Laboratory Inc (Foundation Year, Company Profile and etc.)
-
Table Clinical Reference Laboratory Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clinical Reference Laboratory Inc Cholesterol Lowering Drug Product and Service
-
Table LabCorp (Foundation Year, Company Profile and etc.)
-
Table LabCorp Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LabCorp Cholesterol Lowering Drug Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Cholesterol Lowering Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Cholesterol Lowering Drug Product and Service
-
Table Daiichi Sankyo Company Limited (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Limited Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Limited Cholesterol Lowering Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Cholesterol Lowering Drug Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Cholesterol Lowering Drug Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Cholesterol Lowering Drug Product and Service
-
Table Bristol-Myers Squibb (BMS) (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb (BMS) Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb (BMS) Cholesterol Lowering Drug Product and Service
-
Table Cell Biolabs Inc (Foundation Year, Company Profile and etc.)
-
Table Cell Biolabs Inc Cholesterol Lowering Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Biolabs Inc Cholesterol Lowering Drug Product and Service
-
